Carsten Schmidt-Weber

Director of the Institute of Allergy Research, Helmholtz Munich; Chair of the Center of Allergy and Environment (ZAUM)

+49 89 4140 3450 csweber@tum.de Website

Gebäude / Raum: 57 (office at Biederstein Campus Bldg 653)

"Our research will make a change in the allergy epidemic."

Prof. Schmidt-Weber studied biochemistry and immunology in Darmstadt and Erlangen. He then worked at Harvard Medical School in Boston and at the Swiss Institute for Allergy and Asthma in Davos and at the University of Zurich, where he also wrote his habilitation thesis. From October 2007 to March 2010 he worked and researched at National Hearth and Lung Institute, Imperial College in London. Since 2010 he has been a professor of the newly established Chair of Molecular Allergology at TUM. The institute is also a member of the German Center for Lung Research (DZL) and leads consortium EU projects as well as nationally funded collaborative research projects in addition to numerous individual projects.

T Cell Biology Airway Epithelial Cells Allergen-Specific Immunotherapy Allergy Diagnostics Recombinant Allergens Immunological Tolerance Immunomodulation mRNA-Based Immunotherapy Vaccines

“Our work focuses on immune mechanisms that occur at body surfaces in reaction to environmental triggers. Among those allergens are very relevant, and the question is how the immune system is able to tolerate these components is an important question. Here, the role of epithelial cells is interesting as they are not only forming a barrier against the environment, but also communicate with the immune system. Ways to restore the tolerance to allergens is a goal that may help to control the epidemic of allergies.“

Since 2010

2007-2010

1998-2006

1996-1998

2018 Conference chair of annual meeting of the European Academy of Allergy and Clinical Immunology in Munich
Since 2011 Scientific board member of the IZKF (Interdisziplinäres Zentrum für Klinische Forschung) Jena
2015 Oscar Gans Förderpreis
2007 Prize of the European Academy for Allergy and Asthma Research
2004 Curt-Dehner-Prize

Slusarenko, B.O. ; Borrmann, K.F. ; Knappe, C. ; Vogel, J. ; Schnautz, B. ; Kler, S. ; Biedermann, T. ; Brockow, K. ; Darsow, U. ; Carreno Velazquez, T.L. ; Francescato, E. ; Hewings, S.J. ; Kramer, M.F. ; Heath, M.D. ; Dittmar, G. ; Hilger, C. ; Peters, R.S. ; Schmidt-Weber, C.B. ; Eberlein, B. ; Blank, S.

Assessing the allergenic relevance of Vespula alascensis venom: Implications for venom immunotherapy.

Wasserer, S. ; Seiringer, P. ; Kurzen, N. ; Jargosch, M. ; Eigemann, J. ; Aydin, G. ; Raunegger, T. ; Schmidt-Weber, C.B. ; Eyerich, S. ; Biedermann, T. ; Eyerich, K. ; Lauffer, F.

TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus.

Reddy, K.D. ; Maluje, Y. ; Ott, F. ; Saurabh, R. ; Schaaf, A. ; Bohnhorst, A. ; Biedermann, S.B. ; Pierstorf, J. ; Winkelmann, S. ; Voß, B. ; Laudien, M. ; Bahmer, T. ; Heyckendorf, J. ; Brinkmann, F. ; Schreiber, S. ; Lieb, W. ; Jakwerth, C.A. ; Schmidt-Weber, C.B. ; Hansen, G. ; von Mutius, E. ; Rabe, K.F. ; Dittrich, A.M. ; Maison, N. ; Schaub, B. ; Kopp, M.V. ; Busch, H. ; Weckmann, M. ; Fähnrich, A.

scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.

Prof. Dr. Carsten Schmidt-Weber

On This Page

Academic Pathway & Research Area

Fields of Work and Expertise

Professional Background

Director & Chair: ZAUM – Center of Allergy & Environment, Technical University Munich and Helmholtz Center Munich, Germany

Reader: National Heart & Lung Institute, Imperial College, London (England)

Group leader: Swiss Institute of Allergy and Asthma Research (SIAF), Davos (Switzerland)

PostDoc: Harvard Medical School, Immunology Research Division, Dept. of Pathology, Brigham & Women’s Hospital, Boston (USA

Honors and Awards

Publications

Networks and Affiliations